Bain Capital Life Sciences Investors, LLC

Q2 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    23

  • Value ($000)

    $799,265

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001703031
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
N62509109
$194.12 M
24 %

10,719,110

CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
171757206
$121.81 M
15 %

2,500,680

NUVL
NUVL

NUVALENT INC

COM
670703107
$110.43 M
14 %

1,447,267

---

PHARVARIS N V

COM
N69605108
$58.14 M
7 %

3,303,381

DNTH
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$46.24 M
6 %

2,482,250

YB4P
YB4P

SAVARA INC

COM
805111101
$40.13 M
5 %

17,600,621

---

SOLID BIOSCIENCES INC

COM NEW
83422E204
$38.53 M
5 %

7,911,669

IRON
IRON

DISC MEDICINE INC

COM
254604101
$30.90 M
4 %

583,500

OLMA
OLMA

OLEMA PHARMACEUTICALS INC

COM
68062P106
$29.16 M
4 %

6,843,954

RPID
RPID

RAPID MICRO BIOSYSTEMS INC

CLASS A COM
75340L104
$29.10 M
4 %

8,434,560

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 23